Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-5,485
Closed -$233K – 246
2024
Q1
$233K Buy
+5,485
New +$214K 0.01% 454
2023
Q3
– Sell
-4,769
Closed -$267K – 566
2023
Q2
$267K Buy
4,769
+18
+0.4% +$931 0.01% 410
2023
Q1
$235K Buy
4,751
+209
+5% +$10.6K 0.01% 473
2022
Q4
$214K Buy
+4,542
New +$213K 0.01% 521
2022
Q2
– Sell
-2,879
Closed -$222K – 644
2022
Q1
$222K Buy
+2,879
New +$197K 0.01% 516
2020
Q3
– Sell
-85
Closed -$5K – 274
2020
Q2
$5K Buy
+85
New +$4.62K ﹤0.01% 715
2019
Q3
– Sell
-42
Closed -$2K – 753
2019
Q2
$2K Buy
+42
New +$2.02K ﹤0.01% 616
2018
Q1
– Sell
-206
Closed -$13K – 142
2017
Q4
$13K Hold
206
– – ﹤0.01% 434
2017
Q3
$11K Sell
206
-44
-18% -$2.23K ﹤0.01% 453
2017
Q2
$11K Buy
250
+120
+92% +$5.33K ﹤0.01% 433
2017
Q1
$5K Buy
+130
New +$4.75K ﹤0.01% 462

Other funds holding CGNX

Balentine LLC's CGNX Position: Q2 2024 in Review

Balentine LLC sold out of Cognex (CGNX) in Q2 2024, closing a stake of 5,485 shares — an estimated $233K sold.

Balentine LLC first reported a position in CGNX in Q1 2017 and held it in 11 quarters. The position peaked at $267K in Q2 2023. 443 funds tracked by Wall St. Rank hold CGNX as of Q2 2024.

  • Balentine LLC reported no remaining Cognex position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 5,485 Cognex shares in Q2 2024, an estimated $233K.
  • Balentine LLC first reported a position in Cognex in Q1 2017 and held it in 11 quarters.
  • Balentine LLC's Cognex position peaked at $267K in Q2 2023.
  • 443 funds tracked by Wall St. Rank held Cognex as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.